Yoko Hasumi

Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.

Yoko Hasumi, Hiroaki Mizukami, Masashi Urabe et al. · PubMed · 2002 · 76 citations

Immunology, Pathology, Cancer Biology +20

Prognostic factors and optimal therapy for stages I–II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study

Mitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda et al. · Gynecologic Oncology · 2017 · 73 citations

Prognostic Factors, Optimal Therapy, Endocrine Oncology +8

Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling

Yoko Hasumi, Agnieszka Kłosowska‐Wardęga, Masao Furuhashi et al. · International Journal of Cancer · 2007 · 68 citations · Full text

Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?

Masashi Takano, Hiroyuki Ochi, Yuji Takei et al. · British Journal of Cancer · 2013 · 58 citations · Full text

Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma

Agnieszka Kłosowska‐Wardęga, Yoko Hasumi, Mikhail Burmakin et al. · PLoS ONE · 2009 · 45 citations · Full text

Interstitial Fluid Pressure, Murine Experimental Carcinoma, Pathology +18